HIV continues to be one of the most important communicable diseases in the UK. It is an infection associated with serious morbidity, high costs of treatment and care, significant mortality and high number of potential years of life lost. Each year, many thousands of individuals are diagnosed with HIV for the first time. The infection is still frequently regarded as stigmatising and has a prolonged ‘silent’ period during which it often remains undiagnosed. Highly active antiretroviral therapies have resulted in substantial reductions in AIDS incidence and deaths in the UK.
| HIV Surveillance at HPA | |
|---|---|
Overall HIV PrevalenceHIV prevalence is defined as the proportion of people in a population who are infected with HIV. The HPA conducts a series of surveys (UAPMP) in different populations: pregnant women, injecting drug users and genitourinary medicine clinic attendees. These surveys test anonymised samples and measure the prevalence of both diagnosed and undiagnosed HIV infection. |
|
Receiving HIV careHPA records data for all individuals with diagnosed HIV infection who attend for HIV-related care within the NHS in England. The Survey of Prevalent HIV Infections Diagnosed (SOPHID) is the name of the HPA's surveillance schemes which collects this data. |
|
New HIV DiagnosesThe main sources of information on newly diagnosed HIV/AIDS infection come from voluntary case reporting of HIV/AIDS from laboratory reports of newly diagnosed HIV infections by microbiologists and HIV/AIDS diagnoses by clinicians. |
|
HIV IncidenceHIV incidence is the number of new HIV infections in the population during a certain time period. People who were infected before that time period are not included in the total, even if they are still alive. |
|
HIV Treatment ResistanceData on resistance to antiretroviral treatment in HIV infected drug-naïve individuals is crucial to understanding the epidemiology of transmitted drug resistance, while data from those receiving antiretroviral treatment provides indirect evidence of the contribution of drug resistance to virological failure. |
|
CD4 SurveillanceThe National CD4 Surveillance scheme monitors trends in immunosuppression associated with HIV infection by collecting data on CD4 T-lymphocyte (CD4 cell) counts performed by laboratories in England and Wales. |
|
HIV TestingIncreasing levels of HIV testing in the population and decreasing the proportion of HIV infections which are undiagnosed is an important component in HIV prevention. Individuals who are diagnosed at early stages in their infections respond well to antiretroviral treatment, have improved health outcomes and are less likely to transmit the virus to others. |
|
|
|
HIV in the UK an overview 2011 (PDF, 766 KB)
HIV testing in TB - are we doing enough (PDF, 122 KB)
Treatment as Prevention: Implications for HIV Prevention Programmes (PDF, 292 KB)
Tests of recent infection, RITA programme in the UK (PDF, 633 KB)
HIV Incidence Testing - the patient experience (PDF, 95 KB)
Acceptability of RITA Testing Among Patients and Clinic Staff (PDF, 193 KB)
GUMCAD: Maximising its potential (PDF, 471 KB)
HIV Quality of Care indicators (PDF, 513 KB)
New HIV/AIDS Reporting System (PDF, 139 KB)
GUM ANON survey reinvented (PDF, 235 KB)
Note: For all other presentations please contact HARSQueries@hpa.org.uk.